Skip to content
ExpertPulse UK

Zimbabwe Turns Down ‘Lopsided’ US Healthcare Assistance Deal Due to Information Fears

Health aid image
The offered US funding was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's demand for sensitive information.

The decision became public after a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "skewed".

A government spokesman later clarified that the US was seeking genetic material for scientific study and commercial purposes while was not willing to share the benefits from any future treatments.

"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for continued negotiations to secure a agreement suitable to all parties so the country's vital HIV treatment initiative can continue.

Broader Background

Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were filed about the safety of citizens' medical information.

After returning to office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and accountability.

As per statements, 16 nations in Africa have so far signed these new agreements, representing over $18.3bn of fresh investment.

Specifics of the Rejected Agreement

This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via American-funded initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"Our nation was requested to surrender its genetic material and health information for a long time, with no corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.

"Effectively, our nation would provide the raw materials for scientific discovery with no assurance that the final treatments would be available to our population should a new disease outbreak emerge."

Sovereignty and International Frameworks

He also said that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending structures previously set up through the international organization.

Mangwana cited its Pandemic Benefit-Sharing framework created to manage future global health emergencies.

"This mechanism is designed to ensure that when a country provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."

These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to ongoing discussions with our US partners on how subsequent co-operation might be arranged in a way that honours the sovereignty and interests of each country."

Medical Community Response

A leading public health body stated it acknowledged the government's concerns, but urged that talks should continue since much of the country's Aids initiatives were funded by foreign aid.

"If technical issues exist, including those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it said.

The situation highlights the complex debate between accepting much-needed foreign assistance and protecting a country's data in an ever more data-driven world.

BG
By

Becky Graves

Dr. Sophie Bennett is a seasoned journalist and researcher with a PhD in Digital Media, specializing in tech and health trends.

ExpertPulse UK

Type to search articles.